Abstract | OBJECTIVE: DESIGN: Retrospective comparative study. PATIENTS: We reviewed 33 patients (23 males and 10 females with a mean age of 62.5 years) with histologically-proven progressive IP who were treated with CsA. All patients had corticosteroid-resistant IP or developed acute exacerbation of IP in their courses. RESULTS: The underlying systemic diseases were: idiopathic interstitial pneumonias (IIPs) in 19 patients, and collagen vascular diseases (CVDs) in 14. The histopathological patterns and underlying diseases of IP were classified as usual interstitial pneumonia (UIP)/ idiopathic pulmonary fibrosis (IPF) in 10 patients, cellular-nonspecific interstitial pneumonia (NSIP)/IIPs in 3, fibrotic-NSIP/IIPs in 5, organizing pneumonia (OP)/IIP in 1, UIP/CVDs in 4, cellular-NSIP/CVDs in 7, fibrotic-NSIP/CVDs in 2, and diffuse alveolar damage (DAD)/CVD in 1, respectively. They received a low dosage of CsA combined with corticosteroids. The prognoses after treatment with CsA were well correlated with histopathological patterns. Cellular-NSIP and OP showed better prognoses than fibrotic-NSIP, UIP or DAD. In addition, CVDs had better prognoses than IIPs, when compared on the basis of the same histopathological patterns. Furthermore, the prognoses in the CsA-treated group were significantly better than in those without CsA treatment in regard to acute exacerbation of UIP/IPF. CONCLUSIONS:
|
Authors | Sakae Homma, Susumu Sakamoto, Masateru Kawabata, Kazuma Kishi, Eiyasu Tsuboi, Noriko Motoi, Kunihiko Yoshimura |
Journal | Internal medicine (Tokyo, Japan)
(Intern Med)
Vol. 44
Issue 11
Pg. 1144-50
(Nov 2005)
ISSN: 0918-2918 [Print] Japan |
PMID | 16357451
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Glucocorticoids
- Immunosuppressive Agents
- Cyclosporine
|
Topics |
- Acute Disease
- Aged
- Cyclosporine
(therapeutic use)
- Drug Resistance
- Female
- Follow-Up Studies
- Glucocorticoids
(adverse effects)
- Humans
- Immunosuppressive Agents
(therapeutic use)
- Lung Diseases, Interstitial
(diagnosis, drug therapy, mortality)
- Male
- Middle Aged
- Respiratory Function Tests
- Retrospective Studies
- Survival Rate
- Tomography, X-Ray Computed
- Treatment Outcome
|